GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the peptidylprolyl isomerase domain of arabidopsis thaliana CYP71.

Analyse Crystal structure of the peptidylprolyl isomerase domain of arabidopsis… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6LKB
Type
protein
Length
320 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peptidyl-prolyl cis-trans isomerase CYP71
EC
5.2.1.8
UniProt
Q8W4D0
Ligands
CO, PO4, SO4
Pockets
3 · best druggability 0.33

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPeptidyl-prolyl cis-trans isomerase CYP71 (EC 5.2.1.8)protein16014% helix, 30% strandQ8W4D0

Ligands and binding sites

  • CO · Cobalt (II) ion · metal · 3 copies · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · chains B
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1650.330.7625empty
2510.290.7617empty
3510.260.7414empty

Interfaces

1 interface between chains.

  • A–B · 322 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 6LKB · Crystal Structure of the peptidylprolyl isomerase domain of Arabidopsis thaliana CYP71. · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8W4D0 · AlphaFold monomer V2.0 prediction for peptidyl-prolyl cis-trans isomerase CYP71 (Q8W4D0) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.